Related Experiment Video
Updated: Jun 9, 2025

Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures
Published on: July 25, 2022
Melissa officinalis Regulates Lipopolysaccharide-Induced BV2 Microglial Activation via MAPK and Nrf2 Signaling
Ji-Won Choi1, Sang Yoon Choi1, Guijae Yoo1
1Korea Food Research Institute, Wanju-Gun, Jeollabuk-do 55365, Republic of Korea.
Abstract:
Neuroinflammation and microglial activation play critical roles in neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Modulating microglial activation may help prevent the progression of these disorders. This study aimed to investigate the effects and mechanisms of Melissa officinalis ethanol extract on lipopolysaccharide (LPS)-induced microglial activation in BV2 cells. Cell viability and nitric oxide (NO) production were assessed using MTT assay and Griess reagent, while inflammatory cytokine levels were measured by qPCR. Key inflammatory pathways, including MAPK, TLR4, and antioxidant biomarkers, were analyzed through western blot and immunofluorescence. Rosmarinic acid content in M. officinalis was determined using high-performance liquid chromatography (HPLC). The results demonstrated that M. officinalis ethanol extract significantly inhibited LPS-induced NO production and reduced inflammatory cytokine expression. Additionally, it downregulated inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), TLR4, NF-κB, and MAPK signaling pathways (p38, JNK, ERK), while increasing the expression of antioxidant markers, including Nrf2, HO-1, catalase, and SOD2. In conclusion, M. officinalis ethanol extract exerts neuroprotective effects by modulating inflammation and enhancing antioxidant defenses, suggesting its potential in the prevention and treatment of inflammation-related neurodegenerative diseases.
Insights
Melissa officinalis extract reduces neuroinflammation by inhibiting microglial activation and enhancing antioxidant defenses. This suggests potential therapeutic benefits for neurodegenerative diseases like Alzheimer's and Parkinson's.
Area of Science:
- Neuroscience
- Pharmacology
- Immunology
Background:
- Neuroinflammation and microglial activation are key factors in neurodegenerative diseases.
- Targeting microglial activation may offer a strategy to slow disease progression.
Purpose of the Study:
- To investigate the effects of Melissa officinalis ethanol extract on lipopolysaccharide (LPS)-induced microglial activation.
- To elucidate the underlying mechanisms of action, including inflammatory and antioxidant pathways.
Main Methods:
- BV2 microglial cells were treated with LPS and Melissa officinalis extract.
- Assays included MTT for viability, Griess reagent for nitric oxide (NO), qPCR for cytokines, and western blot/immunofluorescence for signaling pathways (MAPK, TLR4, NF-κB) and antioxidant markers (Nrf2, HO-1, catalase, SOD2).
- High-performance liquid chromatography (HPLC) quantified rosmarinic acid content.
Main Results:
- Melissa officinalis extract significantly inhibited LPS-induced NO production and reduced inflammatory cytokine expression.
- The extract downregulated key inflammatory mediators (iNOS, COX-2, TLR4, NF-κB, MAPK pathways) and upregulated antioxidant markers (Nrf2, HO-1, catalase, SOD2).
Conclusions:
- Melissa officinalis ethanol extract demonstrates neuroprotective properties by modulating neuroinflammation and bolstering antioxidant capacity.
- These findings highlight its potential as a therapeutic agent for neurodegenerative diseases linked to inflammation.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MAPK Signaling Cascades

